It is unclear whether coronary artery stenosis, plaque burden, and composition differ between major epicardial arteries supplying ischemic myocardial territories. We studied 837 symptomatic patients undergoing coronary computed tomography angiography (CTA) and ¹⁵O-water PET myocardial perfusion imaging for suspected obstructive coronary artery disease. Coronary CTA was analyzed using Artificial Intelligence-Guided Quantitative Computed Tomography (AI-QCT) to assess stenosis and atherosclerotic plaque characteristics. Myocardial ischemia was defined by regional PET perfusion in the left anterior descending (LAD), left circumflex (LCX), and right coronary artery (RCA) territories. Among arteries supplying ischemic territories, the LAD exhibited significantly higher stenosis and both absolute and normalized plaque volumes compared to LCX and RCA (p<0.001 for all). Multivariable logistic regression showed diameter stenosis (p=0.001-0.015), percent atheroma volume (PAV; p<0.001), and percent non-calcified plaque volume (p=0.001-0.017) were associated with ischemia across all three arteries. Percent calcified plaque volume was associated with ischemia only in the RCA (p=0.001). The degree of stenosis and atherosclerotic burden are significantly higher in LAD as compared to LCX and RCA, both in epicardial coronary arteries supplying non-ischemic or ischemic myocardial territories. In all the three main coronary arteries both luminal narrowing and plaque burden are independent predictors of ischemia, where the plaque burden is mainly driven by non-calcified plaque. However, many vessels supplying ischemic territories have relatively low stenosis degree and plaque burden, especially in the LCx and RCA, limiting the ability of diameter stenosis and PAV to predict myocardial ischemia.

Bronchial artery chemoembolization (BACE) is a new treatment method for lung cancer. This study aimed to investigate the ability of dual-energy computed tomography (DECT) to predict early recurrence (ER) after BACE among patients with non-small cell lung cancer (NSCLC) who failed first-line therapy. Clinical and imaging data from NSCLC patients undergoing BACE at Wenzhou Medical University Affiliated Fifth *** Hospital (10/2023-06/2024) were retrospectively analyzed. Logistic regression (LR) machine learning models were developed using 5 arterial-phase (AP) virtual monoenergetic images (VMIs; 40, 70, 100, 120, and 150 keV), while deep learning models utilized ResNet50/101/152 architectures with iodine maps. A combined model integrating optimal Rad-score, DL-score, and clinical features was established. Model performance was assessed via area under the receiver operating characteristic curve analysis (AUC), with SHapley Additive exPlanations (SHAP) framework applied for interpretability. A total of 196 patients were enrolled in this study (training cohort: n=158; testing cohort: n=38). The 100 keV machine learning model demonstrated superior performance (AUC=0.751) compared to other VMIs. The deep learning model based on the ResNet101 method (AUC=0.791) performed better than other approaches. The hybrid model combining Rad-score-100keV-A, Rad-score-100keV-V, DL-score-ResNet101-A, DL-score-ResNet101-V, and clinical features exhibited the best performance (AUC=0.798) among all models. DECT holds promise for predicting ER after BACE among NSCLC patients who have failed first-line therapy, offering valuable guidance for clinical treatment planning.

We developed a machine learning model comprising morphological characteristics, enhancement dynamics, and extracellular volume (ECV) fractions for distinguishing malignant and benign small renal masses (SRMs), supporting personalised management. This retrospective analysis involved 230 patients who underwent SRM resection with preoperative imaging, including 185 internal and 45 external cases. The internal cohort was split into training (n=136) and validation (n=49) sets. Histopathological evaluation categorised the lesions as renal cell carcinomas (n=183) or benign masses (n=47). Eleven multiphasic contrast-enhanced computed tomography (CT) parameters, including the ECV fraction, were manually measured, along with clinical and laboratory data. Feature selection involved univariate analysis and least absolute shrinkage and selection operator regularisation. Feature selection informed various machine learning classifiers, and performance was evaluated using receiver operating characteristic curves and classification tests. The optimal model was interpreted using SHapley Additive exPlanations (SHAP). The analysis included 183 carcinoma and 47 benign SRM cases. Feature selection identified seven discriminative parameters, including the ECV fraction, which informed multiple machine learning models. The Extreme Gradient Boosting model incorporating ECV exhibited optimal performance in distinguishing malignant and benign SRMs, achieving area under the curve values of 0.993 (internal training set), 0.986 (internal validation set), and 0.951 (external test set). SHAP analysis confirmed ECV as the top contributor to SRM characterisation. The integration of multiphase contrast-enhanced CT-derived ECV fraction with conventional contrast-enhanced CT parameters demonstrated diagnostic efficacy in differentiating malignant and benign SRMs.

This review synthesizes current evidence regarding optimal breast cancer screening strategies for women with dense breasts, a population at increased risk due to decreased mammographic sensitivity. A systematic literature review was performed in accordance with PRISMA criteria, covering MEDLINE, EMBASE, CINAHL Plus, Scopus, and Web of Science until May 2025. The analysis examines advanced imaging techniques such as digital breast tomosynthesis (DBT), contrast-enhanced spectral mammography (CESM), ultrasound, and magnetic resonance imaging (MRI), assessing their effectiveness in addressing the shortcomings of traditional mammography in dense breast tissue. The review rigorously evaluates the incorporation of risk stratification models, such as the BCSC, in customizing screening regimens, in conjunction with innovative technologies like liquid biopsy and artificial intelligence-based image analysis for improved risk prediction. A key emphasis is placed on the heterogeneity in international screening guidelines and the challenges in translating research findings to diverse clinical settings, particularly in resource-constrained environments. The discussion includes ethical implications regarding compulsory breast density notification and the possibility of intensifying disparities in health care. The review ultimately encourages the development of evidence-based, context-specific guidelines that facilitate equitable access to effective breast cancer screening for all women with dense breasts.

To compare the lesion detectability of hypovascular liver metastases between 70-keV and 40-keV images from dual energy-computed tomography (CT) reconstructed with deep-learning image reconstruction (DLIR). This multi-institutional, retrospective study included adult patients both pre- and post-treatment for gastrointestinal adenocarcinoma. All patients underwent contrast-enhanced CT with reconstruction at 40-keV and 70-keV. Liver metastases were confirmed using gadoxetic acid-enhanced magnetic resonance imaging. Four radiologists independently assessed lesion conspicuity (per-patient and per-lesion) using a 5-point scale. A radiologic technologist measured image noise, tumor-to-liver contrast, and contrast-to-noise ratio (CNR). Quantitative and qualitative results were compared between 70-keV and 40-keV images. The study included 138 patients (mean age, 69 ± 12 years; 80 men) with 208 liver metastases. Seventy-one patients had liver metastases, while 67 did not. Primary cancer sites included 68 cases of pancreas, 50 colorectal, 12 stomach, and 8 gallbladder/bile duct. No significant difference in per-patient lesion detectability was found between 70-keV images (sensitivity, 71.8-90.1%; specificity, 61.2-85.1%; accuracy, 73.9-79.7%) and 40-keV images (sensitivity, 76.1-90.1%; specificity, 53.7-82.1%; accuracy, 71.7-79.0%) (p = 0.18-> 0.99). Similarly, no significant difference in per-lesion lesion detectability was observed between 70-keV (sensitivity, 67.3-82.2%) and 40-keV images (sensitivity, 68.8-81.7%) (p = 0.20-> 0.99). However, Image noise was significantly higher at 40 keV, along with greater tumor-to-liver contrast and CNRs for both hepatic parenchyma and tumors (p < 0.01). There was no significant difference in hypovascular liver metastases detectability between 70-keV and 40-keV images using the DLIR technology.

To assess the efficacy of super-resolution deep learning reconstruction (SR-DLR) with motion reduction algorithm (SR-DLR-M) in mitigating aorta motion artifacts compared to SR-DLR and deep learning reconstruction with motion reduction algorithm (DLR-M). This retrospective study included 86 patients (mean age, 65.0 ± 14.1 years; 53 males) who underwent contrast-enhanced CT including the chest region. CT images were reconstructed with SR-DLR-M, SR-DLR, and DLR-M. Circular or ovoid regions of interest were placed on the aorta, and the standard deviation of the CT attenuation was recorded as quantitative noise. From the CT attenuation profile along a line region of interest that intersected the left common carotid artery wall, edge rise slope and edge rise distance were calculated. Two readers assessed the images based on artifact, sharpness, noise, structure depiction, and diagnostic acceptability (for aortic dissection). Quantitative noise was 7.4/5.4/8.3 Hounsfield unit (HU) in SR-DLR-M/SR-DLR/DLR-M. Significant differences were observed between SR-DLR-M vs. SR-DLR and DLR-M (p < 0.001). Edge rise slope and edge rise distance were 107.1/108.8/85.8 HU/mm and 1.6/1.5/2.0 mm, respectively, in SR-DLR-M/SR-DLR/DLR-M. Statistically significant differences were detected between SR-DLR-M vs. DLR-M (p ≤ 0.001 for both). Two readers scored artifacts in SR-DLR-M as significantly better than those in SR-DLR (p < 0.001). Scores for sharpness, noise, and structure depiction in SR-DLR-M were significantly better than those in DLR-M (p ≤ 0.005). Diagnostic acceptability in SR-DLR-M was significantly better than that in SR-DLR and DLR-M (p < 0.001). SR-DLR-M provided significantly better CT images in diagnosing aortic dissection compared to SR-DLR and DLR-M.

To develop and validate a deep learning model for automated 3D segmentation of rotator cuff muscles on longitudinal CT scans to quantify muscle volume and fat fraction in patients undergoing total shoulder arthroplasty (TSA). The proposed segmentation models adopted DeepLabV3 + with ResNet50 as the backbone. The models were trained, validated, and tested on preoperative or minimum 2-year follow-up CT scans from 53 TSA subjects. 3D Dice similarity scores, average symmetric surface distance (ASSD), 95th percentile Hausdorff distance (HD95), and relative absolute volume difference (RAVD) were used to evaluate the model performance on hold-out test sets. The trained models were applied to a cohort of 172 patients to quantify rotator cuff muscle volumes and fat fractions across preoperative and minimum 2- and 5-year follow-ups. Compared to the ground truth, the models achieved mean Dice of 0.928 and 0.916, mean ASSD of 0.844 mm and 1.028 mm, mean HD95 of 3.071 mm and 4.173 mm, and mean RAVD of 0.025 and 0.068 on the hold-out test sets for the pre-operative and the minimum 2-year follow-up CT scans, respectively. This study developed accurate and reliable deep learning models for automated 3D segmentation of rotator cuff muscles on clinical CT scans in TSA patients. These models substantially reduce the time required for muscle volume and fat fraction analysis and provide a practical tool for investigating how rotator cuff muscle health relates to surgical outcomes. This has the potential to inform patient selection, rehabilitation planning, and surgical decision-making in TSA and RCR.

This study aims to construct and evaluate 8 machine learning models by integrating ultrasound imaging features, clinical characteristics, and serological features to assess the risk of gallbladder cancer (GBC) occurrence in patients. A retrospective analysis was conducted on ultrasound and clinical data of 300 suspected GBC patients who visited the Second Affiliated Hospital of Fujian Medical University from January 2020 to January 2024 and 69 patients who visited the Zhongshan Hospital Affiliated to Xiamen University from January 2024 to January 2025. Key relevant features were selected using Least Absolute Shrinkage and Selection Operator (LASSO) regression. Predictive models were constructed using XGBoost, logistic regression, support vector machine, k-nearest neighbors, random forest, decision tree, naive Bayes, and neural network, with the SHapley Additive exPlanations (SHAP) method employed to explain model interpretability. The LASSO regression demonstrated that gender, age, alkaline phosphatase (ALP), clarity of interface with liver, stratification of the gallbladder wall, intracapsular anechoic lesions, and intracapsular punctiform strong lesions were key features for GBC. The XGBoost model demonstrated an area under receiver operating characteristic curve (AUC) of 0.934, 0.916, and 0.813 in the training, validating, and test sets. SHAP analysis revealed the importance ranking of factors as clarity of interface with liver, stratification of the gallbladder wall, intracapsular anechoic lesions, and intracapsular punctiform strong lesions, ALP, gender, and age. Personalized prediction explanations through SHAP values demonstrated the contribution of each feature to the final prediction, enhancing result interpretability. Furthermore, decision plots were generated to display the influence trajectory of each feature on model predictions, aiding in analyzing which features had the greatest impact on these mispredictions; thereby facilitating further model optimization or feature adjustment. This study proposed a GBC ML model based on ultrasound, clinical, and serological characteristics, indicating the superior performance of the XGBoost model and enhancing the interpretability of the model through the SHAP method.

Brain tumor occurs due to the abnormal development of cells in the brain. It has adversely affected human health, and early diagnosis is required to improve the survival rate of the patient. Hence, various brain tumor detection models have been developed to detect brain tumors. However, the existing methods often suffer from limited accuracy and inefficient learning architecture. The traditional approaches cannot effectively detect the small and subtle changes in the brain cells. To overcome these limitations, a SpinalNet-Quantum Dilated Convolutional Neural Network (Spinal-QDCNN) model is proposed for detecting brain tumors using MRI images. The Spinal-QDCNN method is developed by the combination of QDCNN and SpinalNet for brain tumor detection using MRI. At first, the input brain image is pre-processed using RoI extraction. Then, image enhancement is done by using the thresholding transformation, which is followed by segmentation using Projective Adversarial Networks (PAN). Then, different processes, like random erasing, flipping, and resizing, are applied in the image augmentation phase. This is followed by feature extraction, where statistical features such as average contrast, kurtosis and skewness, and mean, Gabor wavelet features, Discrete Wavelet Transform (DWT) with Gradient Binary Pattern (GBP) are extracted, and finally detection is done using Spinal-QDCNN. Moreover, the proposed method attained a maximum accuracy of 86.356%, sensitivity of 87.37%, and specificity of 88.357%.

Although the use of artificial intelligence (AI) in healthcare is increasing, stakeholder engagement remains poor, particularly relating to understanding parent/carer acceptance of AI tools in paediatric imaging. We explore these perceptions and compare them to the opinions of children and young people (CYAP). A UK national online survey was conducted, inviting parents, carers and guardians of children to participate. The survey was "live" from June 2022 to 2023. The survey included questions asking about respondents' views of AI in general, as well as in specific circumstances (e.g. fractures) with respect to children's healthcare. One hundred forty-six parents/carers (mean age = 45; range = 21-80) from all four nations of the UK responded. Most respondents (93/146, 64%) believed that AI would be more accurate at interpreting paediatric musculoskeletal radiographs than healthcare professionals, but had a strong preference for human supervision (66%). Whilst male respondents were more likely to believe that AI would be more accurate (55/72, 76%), they were twice as likely as female parents/carers to believe that AI use could result in their child's data falling into the wrong hands. Most respondents would like to be asked permission before AI is used for the interpretation of their child's scans (104/146, 71%). Notably, 79% of parents/carers prioritised accuracy over speed compared to 66% of CYAP. Parents/carers feel positively about AI for paediatric imaging but strongly discourage autonomous use. Acknowledging the diverse opinions of the patient population is vital in aiding the successful integration of AI for paediatric imaging. Parents/carers demonstrate a preference for AI use with human supervision that prioritises accuracy, transparency and institutional accountability. AI is welcomed as a supportive tool, but not as a substitute for human expertise. Parents/carers are accepting of AI use, with human supervision. Over half believe AI would replace doctors/nurses looking at bone X-rays within 5 years. Parents/carers are more likely than CYAP to trust AI's accuracy. Parents/carers are also more sceptical about AI data misuse.